Center for Epidemic Preparedness Innovations

BioNTech mpox vaccine, CEPI 100 Days Mission, mRNA orthopoxvirus vaccine, BNT166 phase 1/2 trial, CEPI funding BioNTech, mpox symptoms sculptures, Moderna mpox vaccine,

CEPI funds BioNTech’s mRNA-based mpox vaccine trial with $90 million

Anika Sharma

BioNTech, the German biotech renowned for its groundbreaking mRNA COVID-19 vaccine, is embarking on clinical trials for an mRNA vaccine ...